Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 4601-4650 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT06353347
Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
PHASE3
Active, not recruiting
551 participants
Started: Nov 13, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
64 locations
NCT06181708
Diagnostics in the Leg Ulcer Pathway
N/A
Active, not recruiting
135 participants
Started: Nov 13, 2023 · Completed: Sep 30, 2025
1 condition
2 sponsors
1 location
NCT05708703
Assessing the Time Demands of Cancer
N/A
Active, not recruiting
78 participants
Started: Nov 13, 2023 · Completed: Dec 31, 2030
2 conditions
3 sponsors
2 locations
NCT06219434
Evaluation of a Mindfulness Intervention to Prevent Chemo-brain in Women Preparing for Chemotherapy for Breast Cancer
NA
Active, not recruiting
15 participants
Started: Nov 13, 2023 · Completed: Nov 3, 2025
1 condition
1 sponsor
1 location
NCT06124378
Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer
PHASE2
Active, not recruiting
60 participants
Started: Nov 13, 2023 · Completed: Nov 30, 2026
3 conditions
1 sponsor
1 location
NCT06069544
A Clinical Trial to Evaluate the Safety, Efficacy and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria
PHASE1/PHASE2
Active, not recruiting
163 participants
Started: Nov 13, 2023 · Completed: Mar 31, 2026
1 condition
1 sponsor
5 locations
NCT05774977
Broadband Sound and Sleep
NA
Active, not recruiting
24 participants
Started: Nov 13, 2023 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05986526
The PIFPAF-PFA Study
NA
Active, not recruiting
206 participants
Started: Nov 13, 2023 · Completed: Feb 13, 2028
1 condition
1 sponsor
6 locations
NCT06132841
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD6234 After Repeat Dose Administration in Participants Who Are Overweight or Obese
PHASE1
Active, not recruiting
52 participants
Started: Nov 13, 2023 · Completed: Mar 23, 2026
1 condition
2 sponsors
3 locations
NCT06364254
Effects of CBD on 2 Mile Run Time Trial Performance
NA
Active, not recruiting
30 participants
Started: Nov 11, 2023 · Completed: May 30, 2024
1 condition
1 sponsor
1 location
NCT06100432
Effect of Eurycoma Longifolia (DLBS5055) and Multivitamins (Vitamin C+Vitamin E+ Β-carotene) for Infertile Males
PHASE4
Active, not recruiting
90 participants
Started: Nov 11, 2023 · Completed: Oct 31, 2025
1 condition
2 sponsors
1 location
NCT06173479
Health Belief Model-Based Educational Intervention on Safe Pesticide Use and Biomarkers in Agricultural Workers
NA
Active, not recruiting
66 participants
Started: Nov 11, 2023 · Completed: Jun 30, 2024
4 conditions
2 sponsors
1 location
NCT06767020
Comparative Study on AQP4 Antibody Detection Methods
N/A
Active, not recruiting
120 participants
Started: Nov 11, 2023 · Completed: Jan 27, 2025
1 condition
1 sponsor
1 location
NCT06825312
Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies Against Japanese Encephalitis
PHASE4
Active, not recruiting
600 participants
Started: Nov 11, 2023 · Completed: Dec 31, 2031
1 condition
2 sponsors
6 locations
NCT04024488
Group-Based Intervention to Improve Mental Health and Adherence Among Youth Living With HIV in Low Resource Settings
NA
Active, not recruiting
256 participants
Started: Nov 11, 2023 · Completed: Oct 15, 2025
1 condition
4 sponsors
8 locations
NCT06164951
A Study to Evaluate the Efficacy and Safety of Infigratinib in Children and Adolescents With Achondroplasia
PHASE3
Active, not recruiting
110 participants
Started: Nov 10, 2023 · Completed: Apr 30, 2026
1 condition
1 sponsor
28 locations
NCT06130683
Single-Cell Sequence Technology Used to Reveal Heterogeneity of Secondary Hyperparathyroidism
N/A
Active, not recruiting
12 participants
Started: Nov 10, 2023 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
NCT06132945
A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain
PHASE1
Active, not recruiting
2 participants
Started: Nov 10, 2023 · Completed: Nov 30, 2027
2 conditions
2 sponsors
7 locations
NCT06177223
Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder
NA
Active, not recruiting
200 participants
Started: Nov 10, 2023 · Completed: Apr 10, 2024
1 condition
1 sponsor
1 location
NCT05573243
Clinical Evaluation of Composite Restorations Using Two-steps Universal Adhesive in Non-carious Cervical Lesion (NCCL)
NA
Active, not recruiting
55 participants
Started: Nov 10, 2023 · Completed: Jan 31, 2028
1 condition
1 sponsor
1 location
NCT06305078
Personalized Attention-Deficit/Hyperactivity Disorder (ADHD) Medication Experiment Study
NA
Active, not recruiting
30 participants
Started: Nov 10, 2023 · Completed: May 1, 2025
1 condition
1 sponsor
1 location
NCT06707025
"The Expression of CD24 do-not-eat-me Signal in Cholangiocarcinoma"
N/A
Active, not recruiting
50 participants
Started: Nov 10, 2023 · Completed: Oct 28, 2026
1 condition
1 sponsor
1 location
NCT06148636
A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors
EARLY_PHASE1
Active, not recruiting
24 participants
Started: Nov 10, 2023 · Completed: Nov 20, 2027
5 conditions
4 sponsors
1 location
NCT06154512
A Real-world, Multi-center, Prospective, Observational Study for PNH in China
N/A
Active, not recruiting
724 participants
Started: Nov 10, 2023 · Completed: Nov 30, 2025
1 condition
1 sponsor
40 locations
NCT06169683
Lyric4 Outcomes Evaluation
NA
Active, not recruiting
28 participants
Started: Nov 10, 2023 · Completed: Jan 31, 2024
1 condition
1 sponsor
2 locations
NCT06130020
Comparing Targets of Expressive Writing
NA
Active, not recruiting
159 participants
Started: Nov 10, 2023 · Completed: Sep 30, 2025
3 conditions
1 sponsor
1 location
NCT06161571
A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
PHASE3
Active, not recruiting
700 participants
Started: Nov 10, 2023 · Completed: Oct 31, 2026
2 conditions
1 sponsor
211 locations
NCT06053125
A Study of Adipose Tissue in Adaptive Responses to Exercise
NA
Active, not recruiting
56 participants
Started: Nov 9, 2023 · Completed: Oct 31, 2026
2 conditions
2 sponsors
1 location
NCT06058156
Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis
PHASE2
Active, not recruiting
200 participants
Started: Nov 9, 2023 · Completed: Aug 18, 2026
1 condition
2 sponsors
37 locations
NCT06079164
Study of KITE-197 in Participants With Relapsed or Refractory Large B-cell Lymphoma
PHASE1
Active, not recruiting
39 participants
Started: Nov 9, 2023 · Completed: Jan 31, 2028
1 condition
1 sponsor
11 locations
NCT06124898
Multi-Component Breath Alcohol Intervention
NA
Active, not recruiting
115 participants
Started: Nov 9, 2023 · Completed: Sep 1, 2025
3 conditions
2 sponsors
1 location
NCT06917638
Dental Implant Stability Placed in Healed Bony Sites Using Oversized Drilling Versus Conventional Drilling Protocol
NA
Active, not recruiting
26 participants
Started: Nov 8, 2023 · Completed: May 20, 2026
1 condition
1 sponsor
1 location
NCT07107074
Effects of a Widely Used Vaccine Adjuvant in Subjects With Early Alzheimer's Disease Double-blind Study to Assess the Safety and Efficacy of AD04 in Patients With Early Alzheimer's Disease - ADVANCE
PHASE2
Active, not recruiting
122 participants
Started: Nov 8, 2023 · Completed: Jul 31, 2027
1 condition
1 sponsor
3 locations
NCT06130566
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis
PHASE3
Active, not recruiting
601 participants
Started: Nov 8, 2023 · Completed: Nov 12, 2025
1 condition
1 sponsor
148 locations
NCT05540899
Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer
PHASE1
Active, not recruiting
14 participants
Started: Nov 8, 2023 · Completed: Nov 30, 2028
5 conditions
2 sponsors
1 location
NCT06071091
Permanent Intracranial Stenting for Acute Ischemic Stroke Related to a Refractory Large Vessel Occlusion
NA
Active, not recruiting
346 participants
Started: Nov 8, 2023 · Completed: Aug 1, 2027
1 condition
1 sponsor
13 locations
NCT05604560
A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer
PHASE2
Active, not recruiting
25 participants
Started: Nov 8, 2023 · Completed: Sep 30, 2026
1 condition
3 sponsors
2 locations
NCT06361615
Effect of a Dual-task Intervention Program on Physical and Cognitive Function
NA
Active, not recruiting
24 participants
Started: Nov 8, 2023 · Completed: Apr 5, 2024
2 conditions
1 sponsor
1 location
NCT05953038
LSD Occupancy of the Serotonin 2A Receptor in the Human Brain
EARLY_PHASE1
Active, not recruiting
40 participants
Started: Nov 8, 2023 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT06072183
A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2
PHASE3
Active, not recruiting
1,571 participants
Started: Nov 8, 2023 · Completed: Jul 30, 2027
2 conditions
1 sponsor
230 locations
NCT06010303
A Study to Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
PHASE2
Active, not recruiting
118 participants
Started: Nov 8, 2023 · Completed: May 23, 2026
3 conditions
1 sponsor
38 locations
NCT05904717
Effect of PXS-4728A on Microglia Activation in Participants With Isolated Rapid Eye Movement Sleep Behaviour Disorder
PHASE2
Active, not recruiting
40 participants
Started: Nov 8, 2023 · Completed: Jan 31, 2026
1 condition
1 sponsor
3 locations
NCT06119308
Brief Cognitive Behavioral Therapy to Enhance Benzodiazepine Deprescribing
NA
Active, not recruiting
20 participants
Started: Nov 8, 2023 · Completed: Jun 30, 2025
3 conditions
3 sponsors
1 location
NCT05968716
Addressing Unmet Social Needs Among Hospitalized Children
NA
Active, not recruiting
50 participants
Started: Nov 8, 2023 · Completed: May 31, 2025
6 conditions
2 sponsors
1 location
NCT07156292
The Epidemiology Change From 2006 to 2022 of Infective Endocarditis in Taiwan
N/A
Active, not recruiting
2,247 participants
Started: Nov 8, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05924438
A Randomised, Phase 3 Non-inferiority Study of DOR/3TC/TDF Compared to DTG/TAF/FTC in Participants Infected With HIV-1 Starting First-line Antiretroviral Therapy
PHASE3
Active, not recruiting
600 participants
Started: Nov 8, 2023 · Completed: Jun 30, 2026
1 condition
3 sponsors
1 location
NCT06056895
Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma
PHASE2
Active, not recruiting
12 participants
Started: Nov 8, 2023 · Completed: Apr 30, 2027
3 conditions
2 sponsors
1 location
NCT06087835
Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)
PHASE3
Active, not recruiting
1,835 participants
Started: Nov 7, 2023 · Completed: Jan 22, 2027
1 condition
1 sponsor
296 locations
NCT06065189
Base-edited Autologous Hematopoietic Stem Cell Transplantation in Treating Patients With β-thalassemia Major
EARLY_PHASE1
Active, not recruiting
5 participants
Started: Nov 7, 2023 · Completed: Sep 30, 2025
1 condition
2 sponsors
1 location
NCT06033157
Physiotherapist Supervised Training in Patients With Anterior Shoulder Instability
NA
Active, not recruiting
32 participants
Started: Nov 7, 2023 · Completed: Apr 30, 2027
1 condition
1 sponsor
1 location
Previous
1
More pages
90
91
92
93
94
95
96
More pages
431
Next